{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:02:02Z","timestamp":1791576122890,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021.08031.BD"],"award-info":[{"award-number":["2021.08031.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/148422\/2019"],"award-info":[{"award-number":["SFRH\/BD\/148422\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iNOVA4Health","award":["UIDB\/04462"],"award-info":[{"award-number":["UIDB\/04462"]}]},{"name":"iNOVA4Health","award":["UIDB\/04462"],"award-info":[{"award-number":["UIDB\/04462"]}]},{"name":"LS4FUTURE","award":["LA\/P\/0087\/2020"],"award-info":[{"award-number":["LA\/P\/0087\/2020"]}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["CI23-10380"],"award-info":[{"award-number":["CI23-10380"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011733","name":"Liga Portuguesa Contra o Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-02201-8","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:25:34Z","timestamp":1766150734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neutrophils matter: new clinical insights on their role in the progression of metastatic breast cancer"],"prefix":"10.1186","volume":"27","author":[{"given":"Bruna F.","family":"Correia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Grosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Brites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Telma","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Xavier","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Crist\u00f3v\u00e3o-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Guadalupe","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"3","key":"2201_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2201_CR2","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.3390\/ijms23116271","volume":"23","author":"F Ruscitto","year":"2022","unstructured":"Ruscitto F, Roda N, Priami C, Migliaccio E, Pelicci PG. Beyond genetics: metastasis as an adaptive response in breast cancer. Int J Mol Sci. 2022;23(11):6271.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"2201_CR3","first-page":"6","volume":"12","author":"K Hanna","year":"2021","unstructured":"Hanna K, Mayden K. Chemotherapy treatment considerations in metastatic breast cancer. J Adv Pract Oncol. 2021;12(Suppl 2):6\u201312.","journal-title":"J Adv Pract Oncol"},{"key":"2201_CR4","doi-asserted-by":"publisher","first-page":"1080684","DOI":"10.3389\/fonc.2022.1080684","volume":"13","author":"D Raman","year":"2023","unstructured":"Raman D, Cimpean AM, De Miglio MR, Editorial. Drug resistance in breast cancer\u2014mechanisms and approaches to overcome chemoresistance. Front Oncol. 2023;13:1080684.","journal-title":"Front Oncol"},{"issue":"4","key":"2201_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3892\/ijo.2024.5684","volume":"65","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liang J, Zhang Y, Guo Q. Drug resistance and tumor immune microenvironment: an overview of current understandings. Int J Oncol. 2024;65(4):96.","journal-title":"Int J Oncol"},{"issue":"3","key":"2201_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nat Rev Immunol. 2022;22(3):173\u201387.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2201_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","volume":"41","author":"A Mousset","year":"2023","unstructured":"Mousset A, Lecorgne E, Veillon L, Boissonnas A, Jablonski M, Alcaraz-Perez F, et al. Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-\u03b2 activation. Cancer Cell. 2023;41(4):757\u2013e77510.","journal-title":"Cancer Cell"},{"issue":"7","key":"2201_CR8","doi-asserted-by":"publisher","first-page":"e002242","DOI":"10.1136\/jitc-2020-002242","volume":"9","author":"J Faget","year":"2021","unstructured":"Faget J, Peters S, Quantin X, Meylan E, Bonnefoy N. Neutrophils in the era of immune checkpoint blockade. J Immunother Cancer. 2021;9(7):e002242.","journal-title":"J Immunother Cancer"},{"issue":"16","key":"2201_CR9","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.3390\/cancers14163846","volume":"14","author":"H Arasanz","year":"2022","unstructured":"Arasanz H, Bocanegra AI, Morilla I, Fern\u00e1ndez-Irigoyen J, Mart\u00ednez-Aguillo M, Teijeira L, et al. Circulating low-density neutrophils are associated with resistance to first-line anti-PD1\/PDL1 immunotherapy in non-small cell lung cancer. Cancers (Basel). 2022;14(16):3846.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2201_CR10","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3390\/cancers12102884","volume":"12","author":"L Wu","year":"2020","unstructured":"Wu L, Saxena S, Goel P, Prajapati DR, Wang C, Singh RK. Breast cancer cell-neutrophil interactions enhance neutrophil survival and pro-tumorigenic activities. Cancers (Basel). 2020;12(10):2884.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2201_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00441-017-2777-7","volume":"371","author":"A Rakic","year":"2018","unstructured":"Rakic A, Beaudry P, Mahoney DJ. The complex interplay between neutrophils and cancer. Cell Tissue Res. 2018;371(3):517\u201329.","journal-title":"Cell Tissue Res"},{"issue":"3","key":"2201_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","volume":"16","author":"ZG Fridlender","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell. 2009;16(3):183\u201394.","journal-title":"Cancer Cell"},{"key":"2201_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fimmu.2020.00532","volume":"11","author":"S Leicht","year":"2020","unstructured":"Leicht S, Messerle K, Watzl C. An attempt to polarize human neutrophils toward N1 and N2 phenotypes. Front Immunol. 2020;11:532.","journal-title":"Front Immunol"},{"issue":"1","key":"2201_CR14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12967-014-0347-2","volume":"12","author":"I Mishalian","year":"2014","unstructured":"Mishalian I, Bayuh R, Levy L, Zolotovsky B, Michaeli J, Fridlender ZG, et al. Tumor-associated neutrophils display more anti-tumor phenotype in early stages of tumor development. J Transl Med. 2014;12(1):347.","journal-title":"J Transl Med"},{"issue":"1","key":"2201_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imr.12448","volume":"273","author":"P Scapini","year":"2016","unstructured":"Scapini P, Marini O, Tecchio C, Cassatella MA. Human neutrophils in the Saga of cellular heterogeneity: insights and open questions. Immunol Rev. 2016;273(1):48\u201360.","journal-title":"Immunol Rev"},{"issue":"24","key":"2201_CR16","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.18632\/oncotarget.28135","volume":"12","author":"DP Saraiva","year":"2021","unstructured":"Saraiva DP, Correia BF, Salvador R, de Sousa N, Jacinto A, Braga S, et al. Circulating low-density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses. Oncotarget. 2021;12(24):2388\u2013403.","journal-title":"Oncotarget"},{"issue":"4","key":"2201_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","volume":"10","author":"JY Sagiv","year":"2015","unstructured":"Sagiv JY, Michaeli J, Assi S, Mishalian I, Henke E, Fridlender ZG, Granot Z. Phenotypic diversity and plasticity in Circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10(4):562\u201373.","journal-title":"Cell Rep"},{"issue":"3","key":"2201_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1158\/0008-5472.CAN-03-1808","volume":"64","author":"Y Koga","year":"2004","unstructured":"Koga Y, Matsuzaki A, Suminoe A, Hattori H, Hara T. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res. 2004;64(3):1037\u201343.","journal-title":"Cancer Res"},{"issue":"6","key":"2201_CR19","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","volume":"187","author":"Y Wu","year":"2024","unstructured":"Wu Y, Ma J, Yang X, Fan J, Zhang X, Gao Q, et al. Neutrophil profiling illuminates anti-tumor antigen-presenting potency. Cell. 2024;187(6):1422\u2013e143924.","journal-title":"Cell"},{"issue":"13","key":"2201_CR20","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1016\/j.celrep.2019.05.091","volume":"27","author":"BE Hsu","year":"2019","unstructured":"Hsu BE, Tabari\u00e8s S, Johnson RM, Andrzejewski S, Senecal J, Lehu\u00e9d\u00e9 C, et al. Immature low-density neutrophils exhibit metabolic flexibility that facilitates breast cancer liver metastasis. Cell Rep. 2019;27(13):3902\u201315.","journal-title":"Cell Rep"},{"issue":"2","key":"2201_CR21","first-page":"2311","volume":"34","author":"ME Shaul","year":"2020","unstructured":"Shaul ME, Eyal O, Guglietta S, Aloni P, Zlotnik A, Forkosh E, et al. Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis. FASEB J. 2020;34(2):2311\u201325.","journal-title":"FASEB J"},{"issue":"2","key":"2201_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19(2):177\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2201_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/JLB.5HR0120-459R","volume":"107","author":"M Hassani","year":"2020","unstructured":"Hassani M, Hellebrekers P, Chen N, van Aalst C, Bongers S, Hietbrink F, et al. On the origin of low-density neutrophils. J Leukoc Biol. 2020;107(5):809\u201318.","journal-title":"J Leukoc Biol"},{"issue":"11","key":"2201_CR24","doi-asserted-by":"publisher","first-page":"e1356965","DOI":"10.1080\/2162402X.2017.1356965","volume":"6","author":"J Michaeli","year":"2017","unstructured":"Michaeli J, Shaul ME, Mishalian I, Hovav AH, Levy L, Zolotriov L, et al. Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNF\u03b1 and NO-dependent mechanism, promoting a tumor-supportive environment. OncoImmunology. 2017;6(11):e1356965.","journal-title":"OncoImmunology"},{"issue":"11","key":"2201_CR25","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1136\/gutjnl-2016-313075","volume":"66","author":"TT Wang","year":"2017","unstructured":"Wang TT, Zhao YL, Peng LS, Chen N, Chen W, Lv YP, et al. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut. 2017;66(11):1900\u201311.","journal-title":"Gut"},{"issue":"3","key":"2201_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13045-019-0836-0","volume":"13","author":"LY Yang","year":"2020","unstructured":"Yang LY, Luo Q, Lu L, Zhu WW, Sun HT, Wei R, et al. Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J Hematol Oncol. 2020;13(3):3.","journal-title":"J Hematol Oncol"},{"key":"2201_CR27","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3389\/fonc.2020.01543","volume":"10","author":"DP Saraiva","year":"2020","unstructured":"Saraiva DP, Matias AT, Braga S, Jacinto A, Cabral MG. Establishment of a 3D co-culture with MDA-MB-231 breast cancer cell line and patient-derived immune cells for application in the development of immunotherapies. Front Oncol. 2020;10:1543.","journal-title":"Front Oncol"},{"key":"2201_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1365-3083.1999.00602.x","volume":"50","author":"I Torsteinsd\u00f3ttir","year":"1999","unstructured":"Torsteinsd\u00f3ttir I, Arvidson NG, H\u00e4llgren R, H\u00e5kansson L. Enhanced expression of integrins and CD66b on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis, and the effect of glucocorticoids. Scand J Immunol. 1999;50:433\u20139.","journal-title":"Scand J Immunol"},{"key":"2201_CR29","doi-asserted-by":"crossref","unstructured":"Naeim F, Nagesh Rao P, Song SX, Phan RT. Principles of immunophenotyping. In: Atlas of Hematopathology. 2nd Ed. Academic Press2018. pp. 29\u201356.","DOI":"10.1016\/B978-0-12-809843-1.00002-4"},{"issue":"10","key":"2201_CR30","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.4049\/jimmunol.170.10.5268","volume":"170","author":"I Sabroe","year":"2003","unstructured":"Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN, et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol. 2003;170(10):5268\u201375.","journal-title":"J Immunol"},{"issue":"6","key":"2201_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41389-018-0058-2","volume":"7","author":"U Bat-Erdene","year":"2018","unstructured":"Bat-Erdene U, Quan E, Chan K, Lee BM, Matook W, Lee KY, et al. Neutrophil TLR4 and PKR are targets of breast cancer cell glycosaminoglycans and effectors of glycosaminoglycan-induced APRIL secretion. Oncogenesis. 2018;7(6):45.","journal-title":"Oncogenesis"},{"issue":"3","key":"2201_CR32","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ajpath.2011.05.031","volume":"179","author":"EM Bekes","year":"2011","unstructured":"Bekes EM, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, Quigley JP, et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol. 2011;179(3):1455\u201370.","journal-title":"Am J Pathol"},{"issue":"3","key":"2201_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3892\/ijo.2015.3082","volume":"47","author":"AM Devery","year":"2015","unstructured":"Devery AM, Wadekar R, Bokobza SM, Weber AM, Jiang Y, Ryan AJ. Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer. Int J Oncol. 2015;47(3):849\u201356.","journal-title":"Int J Oncol"},{"issue":"3","key":"2201_CR34","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191(3):677\u201391.","journal-title":"J Cell Biol"},{"issue":"1","key":"2201_CR35","doi-asserted-by":"publisher","first-page":"18240","DOI":"10.1038\/s41598-020-74370-9","volume":"10","author":"M Boettcher","year":"2020","unstructured":"Boettcher M, Esser M, Trah J, Klohs S, Mokhaberi N, Wenskus J, et al. Markers of neutrophil activation and extracellular traps formation are predictive of appendicitis in mice and humans: a pilot study. Sci Rep. 2020;10(1):18240.","journal-title":"Sci Rep"},{"issue":"3","key":"2201_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00262-024-03647-z","volume":"73","author":"A Basnet","year":"2024","unstructured":"Basnet A, Landreth KM, Nohoesu R, Santiago SP, Geldenhuys WJ, Boone BA, et al. Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer. Cancer Immunol Immunother. 2024;73(3):57.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"2201_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3892\/ijo.2017.3883","volume":"50","author":"V Panagopoulos","year":"2017","unstructured":"Panagopoulos V, Leach DA, Zinonos I, Ponomarev V, Licari G, Liapis V, et al. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. Int J Oncol. 2017;50(4):1198\u2013210.","journal-title":"Int J Oncol"},{"issue":"16","key":"2201_CR38","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","volume":"64","author":"PC Rodriguez","year":"2004","unstructured":"Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004;64(16):5839\u201349.","journal-title":"Cancer Res"},{"key":"2201_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00938","volume":"11","author":"TM Grzywa","year":"2020","unstructured":"Grzywa TM, Sosnowska A, Matryba P, Rydzynska Z, Jasinski M, Nowis D, et al. Myeloid cell-derived arginase in cancer immune response. Front Immunol. 2020;11:1\u201324.","journal-title":"Front Immunol"},{"key":"2201_CR40","first-page":"7952869","volume":"12","author":"V Vonwirth","year":"2021","unstructured":"Vonwirth V, B\u00fclb\u00fcl Y, Werner A, Echchannaoui H, Windschmitt J, Habermeier A, et al. Inhibition of arginase 1 liberates potent T cell immunostimulatory activity of human neutrophil granulocytes. Front Immunol. 2021;12:7952869.","journal-title":"Front Immunol"},{"key":"2201_CR41","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946.","journal-title":"Front Immunol"},{"key":"2201_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2022.07.004","volume":"67","author":"W Li","year":"2022","unstructured":"Li W, Wu F, Zhao S, Shi P, Wang S, Cui D. Correlation between PD-1\/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy. Cytokine Growth Factor Rev. 2022;67:49\u201357.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"2201_CR43","doi-asserted-by":"publisher","first-page":"e0265196","DOI":"10.1371\/journal.pone.0265196","volume":"17","author":"DU Purcu","year":"2022","unstructured":"Purcu DU, Korkmaz A, Gunalp S, Helvaci DG, Erdal Y, Dogan Y, et al. Effect of stimulation time on the expression of human macrophage polarization markers. PLoS ONE. 2022;17(3):e0265196.","journal-title":"PLoS ONE"},{"issue":"11","key":"2201_CR44","first-page":"e41416","volume":"123","author":"AI Riggio","year":"2020","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2020;123(11):e41416\u2013020.","journal-title":"Br J Cancer"},{"issue":"3","key":"2201_CR45","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"key":"2201_CR46","first-page":"33008","volume":"63","author":"MO Fj\u00f8rtoft","year":"2024","unstructured":"Fj\u00f8rtoft MO, Huse K, Rye IH. The tumor immune microenvironment in breast cancer progression. Acta Oncol. 2024;63:33008.","journal-title":"Acta Oncol"},{"issue":"1","key":"2201_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10549-021-06337-x","volume":"190","author":"A Hanna","year":"2021","unstructured":"Hanna A, Balko JM. Breast cancer resistance mechanisms: challenges to immunotherapy. Breast Cancer Res Treat. 2021;190(1):5\u201317.","journal-title":"Breast Cancer Res Treat"},{"key":"2201_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01187-y","volume":"14","author":"S Xiong","year":"2021","unstructured":"Xiong S, Dong L, Cheng L. Neutrophils in cancer carcinogenesis and metastasis. J Hematol Oncol. 2021;14:1\u201317.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2201_CR49","doi-asserted-by":"publisher","first-page":"C486","DOI":"10.1152\/ajpcell.00122.2022","volume":"323","author":"JE Str\u00f8bech","year":"2022","unstructured":"Str\u00f8bech JE, Giuriatti P, Erler JT. Neutrophil granulocytes influence on extracellular matrix in cancer progression. Am J Physiol Cell Physiol. 2022;323(2):C486\u201393.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"2201_CR50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10555-015-9594-9","volume":"34","author":"A Swierczak","year":"2015","unstructured":"Swierczak A, Mouchemore KA, Hamilton JA, Anderson RL. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis Rev. 2015;34(4):735\u201351.","journal-title":"Cancer Metastasis Rev"},{"key":"2201_CR51","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun. 2020;11:5120.","journal-title":"Nat Commun"},{"issue":"12","key":"2201_CR52","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.3390\/ijms21124526","volume":"21","author":"G Barillari","year":"2020","unstructured":"Barillari G. The impact of matrix Metalloproteinase-9 on the sequential steps of the metastatic process. Int J Mol Sci. 2020;21(12):4526.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2201_CR53","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/cancers14030536","volume":"14","author":"I Ozel","year":"2022","unstructured":"Ozel I, Duerig I, Domnich M, Lang S, Pylaeva E, Jablonska J. The good, the bad, and the ugly: neutrophils, angiogenesis, and cancer. Cancers (Basel). 2022;14(3):536.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2201_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3892\/etm.2014.1685","volume":"8","author":"J Zhang","year":"2014","unstructured":"Zhang J, Yin L, Wu J, Zhang Y, Xu T, Ma R, et al. Detection of serum VEGF and MMP-9 levels by luminex multiplexed assays in patients with breast infiltrative ductal carcinoma. Exp Ther Med. 2014;8(1):175\u201380.","journal-title":"Exp Ther Med"},{"issue":"5A","key":"2201_CR55","first-page":"3579","volume":"26","author":"H Zheng","year":"2006","unstructured":"Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res. 2006;26(5A):3579\u201383.","journal-title":"Anticancer Res"},{"issue":"5","key":"2201_CR56","doi-asserted-by":"publisher","first-page":"101042831769836","DOI":"10.1177\/1010428317698368","volume":"39","author":"H Gao","year":"2017","unstructured":"Gao H, Lan X, Li S, Xue Y. Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer. Tumour Biol. 2017;39(5):1010428317698368.","journal-title":"Tumour Biol"},{"key":"2201_CR57","doi-asserted-by":"publisher","first-page":"108052","DOI":"10.1016\/j.pharmthera.2021.108052","volume":"236","author":"P Valadez-Cosmes","year":"2022","unstructured":"Valadez-Cosmes P, Raftopoulou S, Mihalic ZN, Marsche G, Kargl J. Myeloperoxidase: growing importance in cancer pathogenesis and potential drug target. Pharmacol Ther. 2022;236:108052.","journal-title":"Pharmacol Ther"},{"key":"2201_CR58","doi-asserted-by":"publisher","first-page":"1418025","DOI":"10.3389\/fimmu.2024.1418025","volume":"15","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang L, Liu S, DeRubeis D, Zhang D. Toll-like receptors in breast cancer immunity and immunotherapy. Front Immunol. 2024;15:1418025.","journal-title":"Front Immunol"},{"key":"2201_CR59","doi-asserted-by":"publisher","first-page":"609579","DOI":"10.1155\/2011\/609579","volume":"2011","author":"A Oblak","year":"2011","unstructured":"Oblak A, Jerala R. Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol. 2011;2011:609579.","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"2201_CR60","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/carcin\/bgv020","volume":"36","author":"A Garc\u00eda-Castro","year":"2015","unstructured":"Garc\u00eda-Castro A, Zonca M, Florindo-Pinheiro D, Carvalho-Pinto CE, Cordero A et al. Guti\u00e9rrez del Burgo B,. APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer. Carcinogenesis. 2015;36(5):574\u2013584.","journal-title":"Carcinogenesis"},{"issue":"10","key":"2201_CR61","first-page":"849","volume":"21","author":"M Zhang","year":"2024","unstructured":"Zhang M, Qin H, Wu Y, Gao Q. Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies. Cancer Biol Med. 2024;21(10):849\u201363.","journal-title":"Cancer Biol Med"},{"key":"2201_CR62","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","volume":"9","author":"MT Masucci","year":"2019","unstructured":"Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front Oncol. 2019;9:1146.","journal-title":"Front Oncol"},{"issue":"2","key":"2201_CR63","doi-asserted-by":"publisher","first-page":"101420","DOI":"10.1016\/j.xcrm.2024.101420","volume":"5","author":"L Wang","year":"2024","unstructured":"Wang L, Guo W, Guo Z, Yu J, Tan J, Simons DL, et al. PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer. Cell Rep Med. 2024;5(2):101420.","journal-title":"Cell Rep Med"},{"issue":"4","key":"2201_CR64","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1158\/1078-0432.CCR-19-1040","volume":"26","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zugazagoitia J, Ahmed FS, Henick BS, Gettinger SN, Herbst RS, et al. Immune cell PD-L1 colocalizes with macrophages and is associated with outcome in PD-1 pathway Blockade therapy. Clin Cancer Res. 2020;26(4):970\u20137.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2201_CR65","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","volume":"68","author":"C Lin","year":"2019","unstructured":"Lin C, He H, Liu H, Li R, Chen Y, Qi Y, et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 2019;68(10):1764\u201373.","journal-title":"Gut"},{"issue":"9","key":"2201_CR66","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.3390\/ijms22094710","volume":"22","author":"DJ Park","year":"2021","unstructured":"Park DJ, Sung PS, Lee GW, Cho SW, Kim SM, Kang BY, et al. Preferential expression of programmed death ligand 1 protein in tumor-associated macrophages and its potential role in immunotherapy for hepatocellular carcinoma. Int J Mol Sci. 2021;22(9):4710.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2201_CR67","doi-asserted-by":"publisher","first-page":"e1412909","DOI":"10.1080\/2162402X.2017.1412909","volume":"7","author":"K Gabrusiewicz","year":"2018","unstructured":"Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, et al. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology. 2018;7(4):e1412909.","journal-title":"Oncoimmunology"},{"key":"2201_CR68","doi-asserted-by":"publisher","first-page":"12007","DOI":"10.1038\/s41598-022-16080-y","volume":"12","author":"K Yonemitsu","year":"2022","unstructured":"Yonemitsu K, Pan C, Fujiwara Y, Miyasato Y, Shiota T, Yano H, et al. GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer. Sci Rep. 2022;12:12007.","journal-title":"Sci Rep"},{"key":"2201_CR69","doi-asserted-by":"publisher","first-page":"e000249","DOI":"10.1136\/bmjonc-2023-000249","volume":"3","author":"A Naing","year":"2024","unstructured":"Naing A, Papadopoulos KP, Pishvaian MJ, Rahma O, Hanna GJ, Garralda E, et al. First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours. BMJ Oncol. 2024;3:e000249.","journal-title":"BMJ Oncol"},{"issue":"7","key":"2201_CR70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/1535-7163.MCT-22-0721","volume":"22","author":"B Borek","year":"2023","unstructured":"Borek B, Nowicka J, Gzik A, Dziegielewski M, Jedrzejczak K, Brzezinska J, et al. Arginase 1\/2 inhibitor OATD-02: from discovery to First-in-man setup in cancer immunotherapy. Mol Cancer Ther. 2023;22(7):807\u201317.","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"2201_CR71","doi-asserted-by":"publisher","first-page":"9782","DOI":"10.3390\/ijms25189782","volume":"25","author":"P Marz\u0119ta-Assas","year":"2024","unstructured":"Marz\u0119ta-Assas P, Jacenik D, Zas\u0142ona Z. Pathophysiology of arginases in cancer and efforts in their pharmacological inhibition. Int J Mol Sci. 2024;25(18):9782.","journal-title":"Int J Mol Sci"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02201-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02201-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02201-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:02:53Z","timestamp":1767045773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-025-02201-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02201-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.04.11.648384","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individuals for the collection of biological samples and clinical data. The study complied with the ethical principles outlined in the Declaration of Helsinki and received approval from the Ethical Committees of HFF, ULSAR, HVFX, HSM, HCD, IPO, and NOVA Medical School.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}